Health-care companies rose after strong earnings from one obesity-drug maker. Eli Lilly shares rose after it reiterated its forecast for 32% 2025 revenue growth, amid rising demand for its Zepbound ...

Elevance Health Inc. closed 31.17% below its 52-week high of $567.26, which the company reached on September 3rd.

Verily, an Alphabet (GOOG) (GOOGL) precision health company, has agreed to sell the company’s Granular insurance business to Elevance Health ...

Stock futures are slightly higher Thursday morning after two straight days of gains have taken major indexes back near all-time highs.

Elevance Health (NYSE:ELV – Get Free Report) was upgraded by research analysts at StockNews.com from a “hold” rating to a ...